Afatinib in combination with pembrolizumab in patients (pts) with stage IIIB/IV squamous cell carcinoma (SCC) of the lung

被引：2
|
作者：
Levy, Benjamin Philip
Paz-Ares, Luis G.
Bennouna, Jaafar
Felip, Enriqueta
Abreu, Delvys Rodriguez
Isla, Dolores
Barlesi, Fabrice
Molinier, Olivier
Madelaine, Jeannick
Audigier-Valette, Clarisse
Kim, Sang-We
Ozguroglu, Mustafa
Erman, Mustafa
Badin, Firas Benyamine
Mekhail, Tarek
Scheff, Ronald J.
Riess, Jonathan W.
机构：
[1] Johns Hopkins Univ, Sch Med, Sibley Mem Hosp, Sidney Kimmel Comprehens Canc Ctr, Washington, DC USA
[2] Hosp Univ 12 Octubre, Madrid, Spain
[3] CNIO, Madrid, Spain
[4] Hop G & L Laennec, Nantes, France
[5] Vall dHebron Univ Hosp, Barcelona, Spain
[6] Hosp Univ Insular Gran Canaria, Las Palmas Gran Canaria, Spain
[7] Hosp Clin Lozano Blesa, Zaragoza, Spain
[8] Hosp Nord Serv Oncol, Marseille, France
[9] Ctr Hosp Le Mans, Le Mans, France
[10] Hopital Cote Nacre, Caen, France
[11] Hop St Musse, Toulon, France
[12] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea
[13] Istanbul Univ, Istanbul, Turkey
[14] Hacettepe Univ, Inst Canc, Ankara, Turkey
[15] Baptist Hlth Lexington Canc Ctr, Lexington, KY USA
[16] Florida Hosp Canc Inst, Orlando, FL USA
[17] Weill Cornell Med Coll, New York, NY USA
[18] Univ Calif Davis, Ctr Comprehens Canc, Sacramento, CA 95817 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.TPS9117
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS9117
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Afatinib in Combination with Pembrolizumab in Patients with Stage IIIB/IV Squamous Cell Carcinoma (SCC) of the Lung
    Riess, J.
    Bennouna, J.
    Paz-Ares, L.
    Chisamore, M.
    Lind, C. Lybeck
    Sadrolhefazi, B.
    Levy, B.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2401 - S2401
  • [2] Immunochemotherapy includes pembrolizumab for stage IIIB lung squamous cell carcinoma: a case report
    Zhang, Shuliang
    Huang, Yizhou
    Chen, Maohui
    Huang, Guanglei
    Zheng, Bin
    Chen, Chun
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (18)
  • [3] Neoadjuvant pembrolizumab with chemotherapy for the treatment of stage IIB-IIIB resectable lung squamous cell carcinoma
    Shen, Dijian
    Wang, Jiangfeng
    Wu, Jie
    Chen, Sheng
    Li, Jianqiang
    Liu, Jinshi
    Chen, Qixun
    Jiang, Youhua
    JOURNAL OF THORACIC DISEASE, 2021, 13 (03) : 1760 - 1768
  • [4] Phase III trial of afatinib vs erlotinib in patients (pts) with squamous cell carcinoma (SCC) of the lung (LUX-Lung 8): EGFR molecular aberrations and survival outcomes
    Park, K.
    Li, W.
    Zhou, C.
    Felip, E.
    Cobo, M.
    Goss, G. D.
    Soria, J. -C.
    Syrigos, K.
    Kraemer, N.
    Chand, V. K.
    Solca, F.
    Lu, S.
    ANNALS OF ONCOLOGY, 2015, 26 : 135 - 135
  • [5] Clinical features of patients with stage IIIB and IV bronchioloalveolar carcinoma of the lung
    Breathnach, OS
    Ishibe, N
    Williams, J
    Linnoila, RI
    Caporaso, N
    Johnson, BE
    CANCER, 1999, 86 (07) : 1165 - 1173
  • [6] Impact of obesity on survival in patients (pts) with early-stage squamous cell carcinoma (SCC) of the oral tongue
    Iyengar, Neil M.
    Kochhar, Amit
    Morris, Patrick Glyn
    Morris, Luc G.
    Zhou, Xi Kathy
    Pino, Alejandro
    Fury, Matthew G.
    Pfister, David G.
    Patel, Snehal G.
    Boyle, Jay
    Hudis, Clifford
    Dannenberg, Andrew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] Pembrolizumab and afatinib for recurrent or metastatic head and neck squamous cell carcinoma
    Kao, H-F.
    Hong, R-L.
    ANNALS OF ONCOLOGY, 2018, 29 : 379 - 379
  • [8] Pembrolizumab and afatinib for recurrent or metastatic head and neck squamous cell carcinoma
    Kao, Hsiang-Fong
    Huang, Huai-Cheng
    Liao, Bin-Chi
    Hong, Ruey-Long
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [9] Afatinib in Combination with Pembrolizumab in Patients with Qquamous Cell Carcinoma of the Lung: a Phase II Study (LUX-Lung IO/KEYNOTE 497)
    Levy, B.
    Bennouna, J.
    Paz-Ares, L.
    Chisamore, M. J.
    Lind, C. L.
    Sadrolhefazi, B.
    Riess, J. W.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1579 - S1579
  • [10] Afatinib With Pembrolizumab for Treatment of Patients With Locally Advanced/Metastatic Squamous Cell Carcinoma of the Lung: The LUX-Lung IO/KEYNOTE 497 Study Protocol
    Levy, Benjamin
    Paz-Ares, Luis
    Bennouna, Jaafar
    Felip, Enriqueta
    Rodriguez Abreu, Delvys
    Isla, Dolores
    Barlesi, Fabrice
    Molinier, Olivier
    Madelaine, Jeannick
    Audigier-Valette, Clarisse
    Kim, Sang-We
    Kim, Hye Ryun
    Ozguroglu, Mustafa
    Erman, Mustafa
    Badin, Firas Benyamine
    Mekhail, Tarek M.
    Scheff, Ronald
    Chisamore, Michael J.
    Sadrolhefazi, Behbood
    Riess, Jonathan W.
    CLINICAL LUNG CANCER, 2019, 20 (03) : E407 - E412
12345